Jia Jie Biomedical Co., Ltd. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 12, 2021 at 06:37 pm EDT
Share
Jia Jie Biomedical Co., Ltd. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced sales was TWD 51.191 million compared to TWD 63.993 million a year ago. Operating loss was TWD 715,000 compared to TWD 29.438 million a year ago. Net loss was TWD 408,000 compared to TWD 24.541 million a year ago. Basic eps - continuing operations was TWD 0 compared to basic loss per share from continuing operations of TWD 0.36 a year ago. For the half year, sales was TWD 105.210 million compared to TWD 138.427 million a year ago. Operating loss was TWD 3.923 million compared to TWD 33.063 million a year ago. Net loss was TWD 3.417 million compared to TWD 27.067 million a year ago. Basic loss per share from continuing operations was TWD 0.04 compared to TWD 0.39 a year ago.
Jia Jie Biomedical Co Ltd is a Taiwan-based company mainly engaged in the processing, production and distribution of turtles and turtle processed products. The Company operates through two business segments. Taiwan Operation segment is engaged in the production and sale of health foods. China Mainland Operation segment is engaged in the production of water purification equipment and related parts. Products are include nutrition and health care series, health water series, home supplies series. Products are mainly sold to Taiwan and mainland China.
JIA JIE BIOMEDICAL CO., LTD. 
